Paul Maroni, MD

Website

Medical School

MD, University of Illinois College of Medicine (2000)

Undergraduate School

BA, University of Virginia (VA) (1996)

Residencies

University of Colorado (University Hospital) Program, Urology (2006)
University of Colorado (University Hospital) Program, Surgery (2002)

Fellowships

Indiana University School of Medicine Program, Urologic Oncology (2007)

Languages

English

Department

Surgery-Urology

Professional Titles

Clinical Director of Urologic Oncology

Recognitions

Top Doc, 5280 Magazine (2019)
Top Doc, 5280 Magazine (2016)
Top Doc, 5280 Magazine (2015)
Top Doc, 5280 Magazine (2014)
Peer selected award for top 4 urologist in Denver Metro Area

Research Interests

I focus on studying quality of life outcomes for patients with prostate cancer and testicular cancer. The ultimate goal is a patient that survives the cancer and returns to a "better than" normal state. A cancer diagnosis is an opportunity to engage in other healthy behaviors.

Publications

Crawford DE, Albala D, Garnick MB, Hahn AW, Maroni P, McKay RR, Miner M, Orio ? P, Pandit K, Sellinger S, Yu EY, Eckel RH. Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways. Can J Urol. 2024 Apr;31(2):11820-11825. PubMed PMID: 38642459
Wiesen B, Atwell M, Leavitt C, Clark N, Kessler E, Lam E, Flaig T, Kukreja J, Kim S, Maroni P, Cost NG. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO Oncol Pract. 2024 Mar;20(3):361-369. PubMed PMID: 38127812
Raina K, Kandhari K, Kant R, Prasad RR, Mishra N, Maurya AK, Fox JT, Sei S, Shoemaker RH, Bosland MC, Maroni P, Agarwal C, Agarwal R. Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against TMPRSS2-ERG (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer. Cancers (Basel). 2023 Oct 19;15(20). PubMed PMID: 37894421
Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 Mar;21(3):236-246. PubMed PMID: 36898362
Meier KM, Meyers ML, Fishbein L, Maroni PD, Cost NG. Multifocal Paraganglioma in Teenager Presenting With Hypertension. Urology. 2023 Feb;172:192-195. PubMed PMID: 36283505
Maroni PJ, Bryant KA, Tatarnic NJ. Female genital concealment and a corresponding male clasping apparatus in Australian ripple bugs (Hemiptera: Veliidae). Arthropod Struct Dev. 2023 May;74:101254. PubMed PMID: 37003094
Raina K, Kandhari K, Kant R, Prasad RR, Mishra N, Maurya AK, Fox JT, Sei S, Shoemaker RH, Bosland MC, Maroni P, Agarwal C, Agarwal R. Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against TMPRSS2-ERG (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer. Cancers (Basel). 2023 Oct 19;15(20). PubMed PMID: 37894421
Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 Mar;21(3):236-246. PubMed PMID: 36898362
Raina K, Kandhari K, Jain AK, Ravichandran K, Maroni P, Agarwal C, Agarwal R. Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model. Cancers (Basel). 2022 Aug 30;14(17). PubMed PMID: 36077751
Raina K, Kant R, Prasad RR, Kandhari K, Tomar M, Mishra N, Kumar R, Fox JT, Sei S, Shoemaker RH, Chen Y, Maroni P, Agarwal C, Agarwal R. Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models. Mol Carcinog. 2022 Jul;61(7):717-734. PubMed PMID: 35452553
Prasad RR, Raina K, Mishra N, Tomar MS, Kumar R, Palmer AE, Maroni P, Agarwal R. Stage-specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis. Mol Carcinog. 2022 May;61(5):454-471. PubMed PMID: 35049094
Raina K, Kandhari K, Jain AK, Ravichandran K, Maroni P, Agarwal C, Agarwal R. Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model. Cancers (Basel). 2022 Aug 30;14(17). PubMed PMID: 36077751
Meier KM, Meyers ML, Fishbein LM, Maroni PD, Cost NG. Multifocal Paraganglioma in Teenager Presenting with Hypertension. Urology. 2022 Oct 22. [Epub ahead of print] PubMed PMID: 36283505
Raina K, Kant R, Prasad RR, Kandhari K, Tomar M, Mishra N, Kumar R, Fox JT, Sei S, Shoemaker RH, Chen Y, Maroni P, Agarwal C, Agarwal R. Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models. Mol Carcinog. 2022 Jul;61(7):717-734. PubMed PMID: 35452553
Makedon A, Maroni P. Median Lobe Urethral Embolus After Focal Ablation of Gleason 7 Prostate Cancer. Oncology (Williston Park). 2021 Jul 13;35(7):422-424. PubMed PMID: 34264568
Pessoa RR, Maroni P, Kukreja J, Kim SP. Comparative effectiveness of robotic and open radical prostatectomy. Transl Androl Urol. 2021 May;10(5):2158-2170. PubMed PMID: 34159098
Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 Dec;39(12):832.e9-832.e15. PubMed PMID: 33820697
Johnson TR, Koul S, Kumar B, Khandrika L, Venezia S, Maroni PD, Meacham RB, Koul HK. Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF. Mol Cancer. 2021 Aug 27;20(1):109. PubMed PMID: 34452613
Makedon A, Maroni P. Median Lobe Urethral Embolus After Focal Ablation of Gleason 7 Prostate Cancer. Oncology (Williston Park). 2021 Jul 13;35(7):422-424. PubMed PMID: 34264568
Pessoa RR, Maroni P, Kukreja J, Kim SP. Comparative effectiveness of robotic and open radical prostatectomy. Transl Androl Urol. 2021 May;10(5):2158-2170. PubMed PMID: 34159098
Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 Dec;39(12):832.e9-832.e15. PubMed PMID: 33820697
Maroni P. Editorial Comment. J Urol. 2020 Oct;204(4):810. PubMed PMID: 32898978
Sheridan A, Maroni P, Patel NU. Tips to start an MR-US fusion biopsy program. Abdom Radiol (NY). 2020 Dec;45(12):4023-4027. PubMed PMID: 32504131
Gore JL, du Plessis M, Zhang J, Dai D, Thompson DJS, Karsh L, Lane B, Franks M, Chen DYT, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim H, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Spratt DE, Davicioni E, Lotan Y, Lin DW. Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial. Pract Radiat Oncol. 2020 Mar - Apr;10(2):e82-e90. PubMed PMID: 31761540
Stanton WN, Crawford ED, Arangua PB, La Rosa FG, van Bokhoven A, Lucia MS, Poage WL, Partin A, Maroni P, Werahera PN. Assessment of high-grade prostate cancer risk using prostate cancer biomarkers. Can J Urol. 2020 Feb;27(1):10080-10085. PubMed PMID: 32065862
Maroni P. Editorial Comment. J Urol. 2020 Oct;204(4):810. PubMed PMID: 32898978
Sheridan A, Maroni P, Patel NU. Tips to start an MR-US fusion biopsy program. Abdom Radiol (NY). 2020 Dec;45(12):4023-4027. PubMed PMID: 32504131
Stanton WN, Crawford ED, Arangua PB, La Rosa FG, van Bokhoven A, Lucia MS, Poage WL, Partin A, Maroni P, Werahera PN. Assessment of high-grade prostate cancer risk using prostate cancer biomarkers. Can J Urol. 2020 Feb;27(1):10080-10085. PubMed PMID: 32065862
Gore JL, du Plessis M, Zhang J, Dai D, Thompson DJS, Karsh L, Lane B, Franks M, Chen DYT, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim H, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Spratt DE, Davicioni E, Lotan Y, Lin DW. Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial. Pract Radiat Oncol. 2020 Mar - Apr;10(2):e82-e90. PubMed PMID: 31761540
Stanton WN, Crawford ED, Arangua PB, La Rosa FG, van Bokhoven A, Lucia MS, Poage WL, Partin A, Maroni P, Werahera PN. Assessment of high-grade prostate cancer risk using prostate cancer biomarkers. Can J Urol. 2020 Feb;27(1):10080-10085. PubMed PMID: 32065862
Aasen DM, Wiedel C, Maroni P, Cohen ME, Meng X, Meguid RA. Association of Hospital Altitude and Postoperative Infectious Complications After Major Operations. High Alt Med Biol. 2019 Dec;20(4):421-426. PubMed PMID: 31618098
Bidikov L, Maroni P, Kim S, Crawford ED. 67-year-old Male with Prostatic Stromal Tumor of Uncertain Malignant Potential. Oncology (Williston Park). 2019 Sep 20;33(9). PubMed PMID: 31571179
Tyagi A, Kumar S, Raina K, Wempe MF, Maroni PD, Agarwal R, Agarwal C. Differential effect of grape seed extract and its active constituent procyanidin B2 3,3?-di-O-gallate against prostate cancer stem cells. Mol Carcinog. 2019 Jul;58(7):1105-1117. PubMed PMID: 30828884
Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct;37(10):2099-2108. PubMed PMID: 30671637
Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY. A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III). J Urol. 2019 Apr;201(4):682-692. PubMed PMID: 30077557
Gore JL, du Plessis M, Zhang J, Dai D, Thompson DJS, Karsh L, Lane B, Franks M, Chen DYT, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim H, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Spratt DE, Davicioni E, Lotan Y, Lin DW. Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial. Pract Radiat Oncol. 2019 Nov 20. [Epub ahead of print] PubMed PMID: 31761540
Aasen DM, Wiedel C, Maroni P, Cohen ME, Meng X, Meguid RA. Association of Hospital Altitude and Postoperative Infectious Complications After Major Operations. High Alt Med Biol. 2019 Dec;20(4):421-426. PubMed PMID: 31618098
Bidikov L, Maroni P, Kim S, Crawford ED. 67-year-old Male with Prostatic Stromal Tumor of Uncertain Malignant Potential. Oncology (Williston Park). 2019 Sep 20;33(9). PubMed PMID: 31571179
Tyagi A, Kumar S, Raina K, Wempe MF, Maroni PD, Agarwal R, Agarwal C. Differential effect of grape seed extract and its active constituent procyanidin B2 3,3?-di-O-gallate against prostate cancer stem cells. Mol Carcinog. 2019 Jul;58(7):1105-1117. PubMed PMID: 30828884
Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct;37(10):2099-2108. PubMed PMID: 30671637
Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY. A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III). J Urol. 2019 Apr;201(4):682-692. PubMed PMID: 30077557
Kessler ER, Su LJ, Gao D, Torkko KC, Wacker M, Anduha M, Chronister N, Maroni P, Crawford ED, Flaig TW, Glode LM, Lam ET. Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integr Cancer Ther. 2018 Dec;17(4):1103-1108. PubMed PMID: 30289005
Robin TP, Maroni PD, Chin BB, La Rosa FG, Bernard B, Pugh TJ. Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification. Oncology (Williston Park). 2018 Jul 15;32(7):360-3, 369, CV3. PubMed PMID: 30080921
Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY. A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence [RADAR] III). J Urol. 2018 Aug 2. [Epub ahead of print] PubMed PMID: 30077557
Maccini MA, Westfall NJ, Van Bokhoven A, Lucia MS, Poage W, Maroni PD, Wilson SS, Glodé LM, Arangua P, Newmark J, Steiner M, Werahera PN, Crawford ED. The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer. Prostate. 2018 May;78(7):506-511. PubMed PMID: 29460452
Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer. Brachytherapy. 2017 Jul - Aug;16(4):790-796. PubMed PMID: 28442277
Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study. Cancer. 2017 Aug 1;123(15):2850-2859. PubMed PMID: 28422278
Amini A, Raben D, Crawford ED, Flaig TW, Kessler ER, Lam ET, Maroni P, Pugh TJ. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database. Urol Oncol. 2017 Jun;35(6):438-446. PubMed PMID: 28214281
Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. J Pediatr Urol. 2017 Aug;13(4):386.e1-386.e7. PubMed PMID: 28153774
Amini A, Waxweiler TV, Maroni PD, Kessler ER, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Survival outcomes of adolescent and adult patients with non-seminomatous testicular germ-cell tumors: A population-based study. J Pediatr Urol. 2016 Dec;12(6):405.e1-405.e9. PubMed PMID: 27544905
Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 Nov;97:138-144. PubMed PMID: 27538802
Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016 May;14(5):509-19. PubMed PMID: 27160230
Amini A, Jones BL, Jackson MW, Rusthoven CG, Maroni P, Kavanagh BD, Raben D. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base. Brachytherapy. 2016 Mar-Apr;15(2):136-46. PubMed PMID: 26825856
Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2016 May;195(5):1453-8. PubMed PMID: 26576709
Werahera PN, Jasion EA, Crawford ED, Lucia MS, van Bokhoven A, Sullivan HT, Kim FJ, Maroni PD, Port JD, Daily JW, La Rosa FG. Diffuse reflectance spectroscopy can differentiate high grade and low grade prostatic carcinoma. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5148-5151. PubMed PMID: 28325017
Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D. Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015 Dec;13(12):1534-61. PubMed PMID: 26656522
Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy (DE-EBRT) Versus Combined Brachytherapy for Intermediate- and High-Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2015 Nov 11. [Epub ahead of print] PubMed PMID: 26576709
Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors. J Pediatr Hematol Oncol. 2015 Nov;37(8):e441-6. PubMed PMID: 26479987
Schlaepfer IR, Nambiar DK, Ramteke A, Kumar R, Dhar D, Agarwal C, Bergman B, Graner M, Maroni P, Singh RP, Agarwal R, Deep G. Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation. Oncotarget. 2015 Sep 8;6(26):22836-56. PubMed PMID: 26087400
Maroni PD. Is radical prostatectomy appropriate for very-high-risk prostate cancer patients? Yes. Oncology (Williston Park). 2015 May;29(5):348, 388. PubMed PMID: 25979543
Schlaepfer IR, Glodé LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH. Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Mol Imaging Biol. 2015 Aug;17(4):529-38. PubMed PMID: 25561013
Schlaepfer IR, Glodé LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH. Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Mol Imaging Biol. 2015 Jan 6. [Epub ahead of print] PubMed PMID: 25561013
Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep;12(9):1211-9; quiz 1219. PubMed PMID: 25190691
Cost NG, Maroni P, Flaig TW. Metastatic relapse after initial clinical stage I testicular Leydig cell tumor. Oncology (Williston Park). 2014 Mar;28(3):211, 214. PubMed PMID: 24855728
Rusthoven CG, Carlson JA, Waxweiler TV, Raben D, Dewitt PE, Crawford ED, Maroni PD, Kavanagh BD. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1064-73. PubMed PMID: 24661660
Maroni P, Moss J. Nephron-sparing surgery. Semin Intervent Radiol. 2014 Mar;31(1):104-6. PubMed PMID: 24596448
Hammond KP, Nielsen C, Linnebur SA, Langness JA, Ray G, Maroni P, Kiser JJ. Priapism induced by boceprevir-CYP3A4 inhibition and a-adrenergic blockade: case report. Clin Infect Dis. 2014 Jan;58(1):e35-8. PubMed PMID: 24092799
Werahera PN, Jasion EA, Crawford ED, La Rosa FG, Lucia MS, van Bokhoven A, Sullivan HT, Port JD, Maroni PD, Daily JW. Systematic diagnosis of prostate cancer using an optical biopsy needle adjunct with fluorescence spectroscopy. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:2165-8. PubMed PMID: 25570414
Garrett K, Okuyama S, Jones W, Barnes D, Tran Z, Spencer L, Lewis K, Maroni P, Chesney M, Marcus A. Bridging the transition from cancer patient to survivor: pilot study results of the Cancer Survivor Telephone Education and Personal Support (C-STEPS) program. Patient Educ Couns. 2013 Aug;92(2):266-72. PubMed PMID: 23647980
Maroni P. In germ cell cancer, are we at the end of the chemotherapy era? Maybe--and we are certainly at the end of the RCT era. Oncology (Williston Park). 2013 Nov;27(11):1136, 1143. PubMed PMID: 24575541
Crawford ED, Rove KO, Barqawi AB, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate. 2013 May;73(7):778-87. PubMed PMID: 23169245
Maroni P, Phillips JM. Hopes and dreams for quality improvement in radical prostatectomy. Oncology (Williston Park). 2012 Jul;26(7):630, 635. PubMed PMID: 22888563
Catarinicchia S, J Phillips, P Maroni. Technical learning from positive margins in robotic assisted laparoscopic prostatectomy: Video assessment of the prostate base in two cases. South Central Section of the AUA, Colorado Springs, CO, October 2012.
Clinical-Pathologic Correlation Between Transperineal Mapping Biopsies of the Prostate and Three-Dimensional Reconstruction of Prostatectomy Specimens. Crawford ED, Rove KO, Barqawi AB, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG. Prostate. 2012 Nov 20.
Hopes and dreams for quality improvement in radical prostatectomy. Maroni P, Phillips JM. Oncology (Williston Park). 2012 Jul;26(7):630, 635.
Flaig TW, Wilson S, van Bokhoven A, Varella-Garcia M, Wolfe P, Maroni P, Genova EE, Morales D, Lucia MS, Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma. Urology. 2011 Oct;78(4):863-7. Epub 2011 Aug 2.
Crawford ED, O'Donnell CI, Barqawi AB, O'Leary M, Sullivan KF, Hughes A, Roehrborn CG, Maroni P. Validation of the modified American Urological Association symptom score. J Urol. 2011 Sep;186(3):945-8. Epub 2011 Jul 24.
Maroni P, Crawford ED. Assessment of men before androgen deprivation therapy. J Urol. 2011 Aug;186(2):371-2. Epub 2011 Jun 15.
Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE Jr, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT; Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group. Collaborators (60)Barry MJ, Williams OD, Meleth S, Cantor A, Lee JY, Wilt TJ, Fong HH, Gerber GS, Gray M, Hoffman FA, Koch G, Litwin M, Lux WE, O'Leary MP, Williams JE Jr, Reda D, McCullough A, Avins AL, Goldberg H, Hamilton L, Huynh C, McVary KT, Brannigan R, Helfand B, Velez M, Schoenecker N, Nickel JC, Morales A, Siemens DR, Downey J, Clark-Pereira J, Crawford ED, Wilson SS, Maroni PD, DeVore P, Jones C, Kreder KJ, Sharp V, Meyerholz D, Eno M, Naslund MJ, Markowitz-Chrystal G, Roehrborn CG, Hornberger B, Beaver A, Carter S, Andriole GL, Gardner V, Whitmore K, Kaplan SA, Te AE, Buckley N, Rodriquez M, Foster HE Jr, Colberg JW, Stavris K, Kusek JW, Nyberg LM, Meyers CM, Betz JM. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011 Sep 28;306(12):1344-51.
Sweaty Koul, Paul Maroni, Binod Kumar, Randall Meacham, Hari Koul. Tetrandrine induces CDK inhibitors (P21 WAF1/CIP1 and P27/KIP1) and suppresses androgen receptor (AR) activity to modulate cell cycle and suppress prostate cancer metastasis. Abstract 231. Presented at the 2010 meeting of the American Urologic Association. San Francisco, CA.
Sweaty Koul, Paul Maroni, Randall Meacham, Hari Koul. Oxalate induced p38 mitogen activated protein kinase kinase-6 (MKK6) in HK-2 cells, a line of human kidney epithelial cells. Abstract 1965. Presented at the 2010 meeting of the American Urologic Association. San Francisco, CA
Sweaty Koul, Binod Kumar, Paul Maroni, Randall Meacham, Hari Koul. Direct effects of Zoledronic acid on hormone responsive and hormone refractory prostate cancer cells. Abstract 104. Presented at the 2010 meeting of the American Urologic Association. San Francisco, CA
Binod Kumar, Paul Maroni, Sweaty Koul, Jeong Seok Hwa, Randall Meacham, Hari Koul. NADPH oxidase mediated ROS-generation is required for hypoxia associated angiogenic signaling in prostate cancer. Abstract 379. Presented at the 2010 meeting of the American Urologic Association. San Francisco, CA
Thomas W. Flaig, Adrie Van Bokhoven, Paul D. Maroni, Shandra Wilson, Leila Garcia, Erin Genova, Pamela Wolfe, Diana Morales, Jennifer Gurshtein, Scott Lucia. The confirmation and prognostic potential of circulating tumor cells in urothelial carcinoma. Presented at the 2010 Genitourinary Cancers Symposium - ASCO. San Francisco, CA
Johnson TR, Koul S, Kumar B, Khandrika L, Venezia S, Maroni PD, Meacham RB, and Koul HK. Loss of PDEF, a prostate derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Mol Cancer 9:148

View All (85 Total)

Professional Memberships

American Urological Association, Member
Rocky Mountain Urological Society, Member
Southwest Oncology Group, Member
University of Colorado Comprehensive Cancer Center, Member
Society of Urologic Oncology, Member

Practice Locations

UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus
1665 Aurora Ct
1st Floor
Aurora, CO 80045
720-848-0170

CU Medicine Urology and Urologic Oncology - South Denver at Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 201 and Suite 301
Highlands Ranch, CO 80129
720-516-1094

UCHealth Highlands Ranch Hospital
1500 Park Central Drive
Highlands Ranch, CO 80129
720-516-1000

CU Medicine Urology - South Denver at Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 201 and Suite 301
Highlands Ranch, CO 80129
303-265-3940

Hospital Affiliation

University of Colorado Hospital
UCHealth Highlands Ranch Hospital

Center Affiliations

University of Colorado Cancer Center

Specialty Information

Specialties

Urology, Board Certification (, 2009)
Urologic Oncology
MD, License (2000)

Conditions & Treatments

Surgery
Surgery - Robotic Surgery
Cancers - Kidney Cancer
Cancers - Prostate Cancer
Cancers - Testicular Cancer
Surgery - Urologic Surgery
Cancers - Urologic Cancer
Cancers
Transgender Health for Adults
Men's Health - Prostate Conditions
Men's Health

Clinical Interests
My main interests are robotic or daVinci surgery for prostate or kidney cancer. I have done over 1500 robotic prostate removals (as of 2023). I care a great deal about doing a good job with this operation including nerve-sparing surgery when appropriate. I also specialize in complex abdominal surgery for metastatic testicular cancer. This operation is called Retroperitoneal Lymph Node Dissection or RPLND. Testimonial from a prostate cancer patient: "Please feel free to use my story as needed to reassure future Prostate Cancer victims...and Radical Prostatectomy candidates/patients in general...that there is indeed life after a cancer diagnosis and that a Prostatectomy (at least one done with your skills) won't keep them from taking on strenuous physical challenges." I also treat men with enlargement of the prostate gland. I perform a number of procedures including Holmium Laser Enucleation of the Prostate or HoLEP. HoLEP is a great operation for men with prostate enlargement. EAU Robotic Prostatectomy Video https://www.youtube.com/watch?v=HK-bW-I0EIU

Care Philosophy
A diagnosis of cancer is awful. I view the patient relationship as a partnership and focus on educating in clear terms. I try my best to give every patient the time they deserve. We use a team approach to provide the very best cancer care! Additionally, I am interested in the lifelong health of an individual and strongly promote healthy behaviors but sometimes people live better through chemistry (that is, treat high cholesterol, high blood pressure, and sometimes weight with medications). If interested, I would recommend reading Outlive by Dr Peter Attia and Forever Strong by Dr Gabrielle Lyon.

Personal Interests
In my spare time, I enjoy spending time with my family, running, hiking, snowboarding, and resistance training.

Volunteer Activities
I’m a member of the Grandview High School Baseball Booster Board.

Public Speaking
Yes
I speak at regional and national meetings about physician wellness and burnout.

Associate Professor, Surgery-Urology